CD4 and melanoma: TILs are a polyclonal population, which consists of CD20+ B cells, CD3+ T-cells (CD4+ and CD8+ T-cells), and FOXP3+ regulatory T-cells [20], whose prognostic role in melanoma is currently under investigation [21].